{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=APAP&page=21", "query": { "intervention": "APAP", "page": 21 }, "page_size": 10 }, "pagination": { "page": 21, "page_size": 10, "total_count": 979, "total_pages": 98, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=APAP&page=22&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=APAP&page=20&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-23T16:36:23.429Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04413799", "title": "PVB vs Ketamine/Lidocaine in Rib Fracture Patients", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Rib Fractures", "Rib Trauma", "Rib Fracture Multiple", "Pain, Acute" ], "interventions": [ { "name": "lidocaine, ketamine intravenous infusion", "type": "COMBINATION_PRODUCT" }, { "name": "paravertebral block with ropivicaine", "type": "DRUG" } ], "intervention_types": [ "COMBINATION_PRODUCT", "DRUG" ], "sponsor": "George Washington University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 32, "start_date": "2020-09-01", "completion_date": "2025-01-01", "has_results": false, "last_update_posted_date": "2025-06-22", "last_synced_at": "2026-10-23T16:36:23.429Z", "location_count": 1, "location_summary": "Washington D.C., District of Columbia", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT04413799" }, { "nct_id": "NCT02159885", "title": "Telemedici ne Management of Veterans With Newly Diagnosed Obstructiv e Sleep Apnea (OSA)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Obstructive Sleep Apnea" ], "interventions": [ { "name": "Telemonitoring", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Corporal Michael J. Crescenz VA Medical Center", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 53, "start_date": "2014-04", "completion_date": "2016-07", "has_results": false, "last_update_posted_date": "2016-08-10", "last_synced_at": "2026-10-23T16:36:23.429Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT02159885" }, { "nct_id": "NCT03756038", "title": "Benzodiazepines for the Reduction of Distress and Pain During and After Emergency Department Care", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acute Pain" ], "interventions": [ { "name": "Placebos", "type": "DRUG" }, { "name": "Lorazepam", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Maria Pacella", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 1, "start_date": "2019-01-25", "completion_date": "2019-03-27", "has_results": true, "last_update_posted_date": "2020-03-09", "last_synced_at": "2026-10-23T16:36:23.429Z", "location_count": 2, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" }, { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT03756038" }, { "nct_id": "NCT01231204", "title": "Prevention of Post-Mastectomy Breast Pain Using Ambulatory Continuous Paravertebral Blocks", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Paravertebral Catheter Insertion", "Mastectomy", "Breast Cancer" ], "interventions": [ { "name": "Placebo (normal saline) Continuous Infusion", "type": "PROCEDURE" }, { "name": "Ropivicaine 0.4% Continuous Infusion", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "University of California, San Diego", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 60, "start_date": "2010-10", "completion_date": "2016-03", "has_results": false, "last_update_posted_date": "2016-04-11", "last_synced_at": "2026-10-23T16:36:23.429Z", "location_count": 1, "location_summary": "La Jolla, California", "locations": [ { "city": "La Jolla", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01231204" }, { "nct_id": "NCT06036784", "title": "Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of MBX 1416 in Healthy Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Postbariatric Hypoglycemia" ], "interventions": [ { "name": "MBX 1416 (Part A)", "type": "DRUG" }, { "name": "MBX 1416 (Part B)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "MBX 1416 (Part C)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "MBX Biosciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 69, "start_date": "2023-09-18", "completion_date": "2024-12-05", "has_results": false, "last_update_posted_date": "2024-12-12", "last_synced_at": "2026-10-23T16:36:23.429Z", "location_count": 1, "location_summary": "Chula Vista, California", "locations": [ { "city": "Chula Vista", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06036784" }, { "nct_id": "NCT05597878", "title": "Opioid-Free Pain Control Regimen Following Robotic Radical Prostatectomy", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Pain Management", "Opioid Use", "Prostate Cancer" ], "interventions": [ { "name": "Oxycodone", "type": "DRUG" }, { "name": "Acetaminophen", "type": "DRUG" }, { "name": "Ketamine", "type": "DRUG" }, { "name": "Ketorolac", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Wake Forest University Health Sciences", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "75 Years", "sex": "MALE", "summary": "40 Years to 75 Years · Male only" }, "enrollment_count": 58, "start_date": "2023-04-18", "completion_date": "2026-02-26", "has_results": false, "last_update_posted_date": "2026-06-15", "last_synced_at": "2026-10-23T16:36:23.429Z", "location_count": 1, "location_summary": "Winston-Salem, North Carolina", "locations": [ { "city": "Winston-Salem", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT05597878" }, { "nct_id": "NCT05896228", "title": "Iberdomide, Daratumumab, Carfilzomib, and Dexamethasone (Iber-KDd) in Patients With Relapsed/Refractory Multiple Myeloma", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Refractory Multiple Myeloma", "Relapsed Multiple Myeloma" ], "interventions": [ { "name": "Iberdomide", "type": "DRUG" }, { "name": "Carfilzomib", "type": "DRUG" }, { "name": "Daratumumab", "type": "DRUG" }, { "name": "Dexamethasone", "type": "DRUG" }, { "name": "Acetaminophen", "type": "DRUG" }, { "name": "Diphenhydramine", "type": "DRUG" }, { "name": "Montelukast", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Benjamin T Diamond, MD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 30, "start_date": "2024-02-20", "completion_date": "2031-03-01", "has_results": false, "last_update_posted_date": "2026-03-11", "last_synced_at": "2026-10-23T16:36:23.429Z", "location_count": 1, "location_summary": "Miami, Florida", "locations": [ { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05896228" }, { "nct_id": "NCT00012857", "title": "Pain Management and Behavioral Outcomes in Patients With Dementia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Dementia", "Alzheimer Disease, Pain", "Behavior, Agitation" ], "interventions": [ { "name": "acetaminophen 650 mg qid and placebo qid PRN. The other arm was placebo qid and acetaminophen 650 mg qid PRN", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "US Department of Veterans Affairs", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "55 Years", "maximum_age": null, "sex": "ALL", "summary": "55 Years and older" }, "enrollment_count": 66, "start_date": null, "completion_date": "2001-03", "has_results": false, "last_update_posted_date": "2015-04-07", "last_synced_at": "2026-10-23T16:36:23.429Z", "location_count": 1, "location_summary": "Palo Alto, California", "locations": [ { "city": "Palo Alto", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00012857" }, { "nct_id": "NCT01451502", "title": "Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Lymphatic Diseases", "Hematopoietic Malignancy" ], "interventions": [ { "name": "Umbilical Cord Blood (UCB)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Masonic Cancer Center, University of Minnesota", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 250, "start_date": "2011-10-20", "completion_date": "2028-02", "has_results": false, "last_update_posted_date": "2026-10-06", "last_synced_at": "2026-10-23T16:36:23.429Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT01451502" }, { "nct_id": "NCT07076069", "title": "The Effect of Multimodal Pain Regimen on Use of Narcotics After Rotator Cuff Tear Repair", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Rotator Cuff Repairs", "Pain Management" ], "interventions": [ { "name": "Multimodal Pain Regimen", "type": "DRUG" }, { "name": "Standard of Care Pain Regimen", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Montefiore Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 130, "start_date": "2025-07-21", "completion_date": "2028-06", "has_results": false, "last_update_posted_date": "2026-07-13", "last_synced_at": "2026-10-23T16:36:23.429Z", "location_count": 1, "location_summary": "The Bronx, New York", "locations": [ { "city": "The Bronx", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT07076069" } ] }